These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. A survey of European and Canadian rheumatologists regarding the treatment of patients with ankylosing spondylitis and extra-articular manifestations. Van den Bosch F Clin Rheumatol; 2010 Mar; 29(3):281-8. PubMed ID: 19957003 [TBL] [Abstract][Full Text] [Related]
23. Therapies for dactylitis in psoriatic arthritis. A systematic review. Helliwell PS J Rheumatol; 2006 Jul; 33(7):1439-41. PubMed ID: 16724369 [TBL] [Abstract][Full Text] [Related]
24. PsART-ID inception cohort: clinical characteristics, treatment choices and outcomes of patients with psoriatic arthritis. Ayan G; Aydin SZ; Kimyon G; Ozisler C; Tinazzi I; Dogru A; Omma A; Kilic L; Yılmaz S; Kucuksahin O; Gönüllü E; Yıldız F; Can M; Balkarlı A; Solmaz D; Dalkılıc E; Bayindir O; Yıldırım Çetin G; Ergulu Esmen S; Ersozlu ED; Duruoz MT; Akyol L; Kucuk A; Bes C; Cınar M; Erden A; Mercan R; Bakirci S; Kasifoglu T; Yazısız V; Kalyoncu U Rheumatology (Oxford); 2021 Apr; 60(4):1755-1762. PubMed ID: 33097960 [TBL] [Abstract][Full Text] [Related]
25. Axial involvement in psoriatic arthritis: An update for rheumatologists. Poddubnyy D; Jadon DR; Van den Bosch F; Mease PJ; Gladman DD Semin Arthritis Rheum; 2021 Aug; 51(4):880-887. PubMed ID: 34198146 [TBL] [Abstract][Full Text] [Related]
26. Canadian Rheumatologists' Perspectives on Moderate Psoriatic Arthritis and Oligoarticular Psoriatic Arthritis. Gladman DD; Starr M; Cividino A; Gaudreau AJ; Jelley J; Nicholson D; Karsh J J Rheumatol; 2021 Nov; 48(11):1692-1697. PubMed ID: 33993114 [TBL] [Abstract][Full Text] [Related]
27. [Medical care situation of patients with ankylosing spondylitis and psoriatic arthritis in Germany : Medical care situation of patients with spondyloarthritis (SpA): ankylosing spondylitis (AS) and psoriatic arthritis (PsA) from the perspective of rheumatologists in private practice and hospitals in Germany-Results of the research project "SpA Loop-Life of Outpatients"]. Braun J; Schwarting A; Hammel L; Legeler C; Wimmer P; Färber L; Behrens F Z Rheumatol; 2019 May; 78(4):372-381. PubMed ID: 30874934 [TBL] [Abstract][Full Text] [Related]
28. Disease-modifying antirheumatic drug therapy for psoriatic arthritis. Salvarani C; Cantini F; Olivieri I Clin Exp Rheumatol; 2002; 20(6 Suppl 28):S71-5. PubMed ID: 12463452 [TBL] [Abstract][Full Text] [Related]
29. Can traditional disease-modifying anti-rheumatic drugs be withdrawn or tapered in psoriatic arthritis? Lubrano E; Soriano E; FitzGerald O Clin Exp Rheumatol; 2013; 31(4 Suppl 78):S54-8. PubMed ID: 24129139 [TBL] [Abstract][Full Text] [Related]
30. ALIGN PsA: Advancing a Multidisciplinary Approach in PsA. Baum EW; Schwartzman S Semin Cutan Med Surg; 2018 Dec; 37(6S):S125-S134. PubMed ID: 30605493 [TBL] [Abstract][Full Text] [Related]
31. Psoriatic arthritis: treatment strategies using anti-inflammatory drugs and classical DMARDs. Lubrano E; Scarpa R Reumatismo; 2012 Jun; 64(2):107-12. PubMed ID: 22690387 [TBL] [Abstract][Full Text] [Related]
32. [[WHAT SHOULD BE KNOWN ABOUT PSORIATIC ARTHRITIS]?]. Kehler T; Čabrijan L Acta Med Croatica; 2015; 69(2):111-5. PubMed ID: 29076711 [TBL] [Abstract][Full Text] [Related]
33. Tailored first-line biologic therapy in patients with rheumatoid arthritis, spondyloarthritis, and psoriatic arthritis. Cantini F; Niccoli L; Nannini C; Cassarà E; Kaloudi O; Giulio Favalli E; Becciolini A; Biggioggero M; Benucci M; Li Gobbi F; Grossi V; Infantino M; Meacci F; Manfredi M; Guiducci S; Bellando-Randone S; Matucci-Cerinic M; Foti R; Di Gangi M; Mosca M; Tani C; Palmieri F; Goletti D; Semin Arthritis Rheum; 2016 Apr; 45(5):519-32. PubMed ID: 26607440 [TBL] [Abstract][Full Text] [Related]
34. Frequency of iridocyclitis in patients with early psoriatic arthritis: a prospective, follow up study. Niccoli L; Nannini C; Cassarà E; Kaloudi O; Susini M; Lenzetti I; Cantini F Int J Rheum Dis; 2012 Aug; 15(4):414-8. PubMed ID: 22898222 [TBL] [Abstract][Full Text] [Related]
35. Psoriatic arthritis: current therapy and future approaches. Huynh D; Kavanaugh A Rheumatology (Oxford); 2015 Jan; 54(1):20-8. PubMed ID: 25125588 [TBL] [Abstract][Full Text] [Related]
36. Current practice, trends and attitudes of rheumatologists towards glucocorticoids use for rheumatoid arthritis (GURANTEE): a national cross-sectional survey across China. Xie W; Huang H; Geng Y; Fan Y; Zhang Z Rheumatol Int; 2024 Nov; 44(11):2473-2482. PubMed ID: 39261371 [TBL] [Abstract][Full Text] [Related]
38. Treatment strategies for psoriatic arthritis. Schemoul J; Poulain C; Claudepierre P Joint Bone Spine; 2018 Oct; 85(5):537-544. PubMed ID: 29155104 [TBL] [Abstract][Full Text] [Related]
39. Efficacy of certolizumab pegol with and without concomitant use of disease-modifying anti-rheumatic drugs over 4 years in psoriatic arthritis patients: results from the RAPID-PsA randomized controlled trial. Walsh JA; Gottlieb AB; Hoepken B; Nurminen T; Mease PJ Clin Rheumatol; 2018 Dec; 37(12):3285-3296. PubMed ID: 30191421 [TBL] [Abstract][Full Text] [Related]
40. Recommendations for the use of biologics and other novel drugs in the treatment of psoriatic arthritis: 2017 update from the Italian Society of Rheumatology. Marchesoni A; Olivieri I; Salvarani C; Pipitone N; D'Angelo S; Mathieu A; Cauli A; Punzi L; Ramonda R; Scarpa R; Maccarone M; Lubrano E Clin Exp Rheumatol; 2017; 35(6):991-1010. PubMed ID: 29185959 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]